Genetron Health Announces NMPA Approval of its 8-gene Lung Cancer Assay and NGS Platform GENETRON S2000
(WorldNews Health)

BEIJING--(BUSINESS WIRE)--Feb 13, 2020-- Genetron Holdings Limited (`Genetron Health`), a China-based precision oncology company that covers full-cycle cancer care, announced that the National Medical Products Administration (NMPA) has approved its 8-gene Lung Cancer Assay and high-throughput NGS platform GENETRON S2000 to empower comprehensive panel genomic testing for more patients. The 8-gene Lung Cancer Assay is the first lung cancer clinical testing assay based on Genetron One-Step Seq Method approved by NMPA, offering fast and easy-to-use testing procedures, that is...